A misleading presentation: skin sarcoma presenting as a breast mass

Authors

  • Maryam Hassanesfahani Department of General Surgery, Flushing Hospital Medical Centre, Flushing, NY, USA
  • Mrinalini Alla Department of General Surgery, Flushing Hospital Medical Centre, Flushing, NY, USA
  • Loryn Bucci New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, USA
  • Noman Khan Department of General Surgery, Flushing Hospital Medical Centre, Flushing, NY, USA

DOI:

https://doi.org/10.18203/2349-2902.isj20253030

Keywords:

Atypical fibroxanthoma, Cutaneous sarcoma, Pleomorphic dermal sarcoma, Breast mass

Abstract

Atypical fibroxanthoma (AFX) is a rare cutaneous malignant neoplasm which manifests as solitary lesions in sun-exposed areas of elderly patients, commonly on the head and neck. Given AFX’s rarity and lack of specific immunohistological markers, there are no established standardized guidelines for the management of AFX, often leading to a misdiagnosis of more aggressive variants such as pleomorphic dermal sarcoma (PDS). The prognosis is generally favorable, with most cases responding well to complete surgical excision alone. We present a rare case of AFX in the breast, a 68-year-old woman with a left breast mass, which the patient described as a small pimple. A computed tomography (CT) scan revealed a superficially located lesion in the upper medial quadrant of the left breast, measuring 4.2×2.2×2.1 cm (Figure 1A, B). At the patient’s request, she proceeded with upfront wide local excision without prior biopsy or any breast imaging.  Histopathological examination revealed a well-circumscribed tumor measuring 3.8×3.3 cm, with no connection to the overlying epidermis (Figure 1C). Given that the surgical margin was less than 1 cm, the patient underwent a re-excision with sentinel lymph node biopsy. Final pathology was negative for positive margins and any lymph node involvement. At one-year follow-up, there was no clinical or radiological evidence of recurrence or metastasis. This case highlights the importance of including cutaneous lesions in the differential diagnosis of breast masses located near the skin surface. Accurate diagnosis requires a high index of suspicion and meticulous histopathological evaluation.

Metrics

Metrics Loading ...

References

McClure E, Carr MJ, Patel A. Atypical fibroxanthoma: outcomes from a large single institution series. Cancer Control. 2023;30:10699. DOI: https://doi.org/10.1177/10732748231155699

Ziemer M. Atypical fibroxanthoma. J Dtsch Dermatol Ges. 2012;10(8):537-50. DOI: https://doi.org/10.1111/j.1610-0387.2012.07980_suppl.x

Woodson J, Baha A, Verma N. Case study of atypical fibroxanthoma: presentation and management. Cureus. 2024;16(2):55094. DOI: https://doi.org/10.7759/cureus.55094

Anders IM, Schimmelpfennig C, Wiedemann K. Atypical fibroxanthoma and pleomorphic dermal sarcoma-gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges. 2023;21(5):482-91. DOI: https://doi.org/10.1111/ddg.15006

Orholt M, Abebe K, Aaberg F. Immunohistochemical characteristics of atypical fibroxanthoma and pleomorphic dermal sarcoma: a systematic review and meta-analysis. Am J Dermatopathol. 2022;44(12):913-20. DOI: https://doi.org/10.1097/DAD.0000000000002305

Tolkachjov SN, Kelley BF, Alahdab F, Erwin PJ, Brewer JD. "Atypical fibroxanthoma: systematic review and meta-analysis of treatment with mohs micrographic surgery or excision." (“atypical fibroxanthoma and related cutaneous sarcomas”. J Am Acad Dermatol. 2018;79(5):929-34. DOI: https://doi.org/10.1016/j.jaad.2018.06.048

Iorizzo, Luciano J, Marc D. Atypical fibroxanthoma: a review of the literature. Dermatol Surg. 2023;37(2):146-57. DOI: https://doi.org/10.1111/j.1524-4725.2010.01843.x

Davidson JS, Demsey D. Atypical fibroxanthoma: clinicopathologic determinants for recurrence and implications for surgical management. J Surg Oncol. 2012;105(6):559-62. DOI: https://doi.org/10.1002/jso.22128

Sakamoto A, Oda Y, Itakura E, Oshiro Y, Tamiya S, Honda Y, et al. H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma. Hum Pathol. 2001;32(11):1225-31. DOI: https://doi.org/10.1053/hupa.2001.28953

Helbig D, Ziemer M, Dippel E, Erdmann M, Hillen U, Leiter U, et al. S1-guideline atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS). J Dtsch Dermatol Ges. 2022;20(2):235-43. DOI: https://doi.org/10.1111/ddg.14700

Downloads

Published

2025-09-25

How to Cite

Hassanesfahani, M., Alla, M., Bucci, L., & Khan, N. (2025). A misleading presentation: skin sarcoma presenting as a breast mass. International Surgery Journal, 12(10), 1784–1786. https://doi.org/10.18203/2349-2902.isj20253030

Issue

Section

Case Reports